Follow this preprint
PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial
Francisco J. Martinez, Michael White, Micheline Guillotte-Blisnick, Christèle Huon, Alix Boucharlat, Fabrice Agou, View ORCID ProfilePatrick England, Jean Popovici, View ORCID ProfileMimi M. Hou, Sarah E. Silk, Jordan R. Barrett, Carolyn M. Nielsen, Jenny M. Reimer, Paushali Mukherjee, Virander S. Chauhan, View ORCID ProfileAngela M. Minassian, View ORCID ProfileSimon J. Draper, View ORCID ProfileChetan E. Chitnis
doi: https://doi.org/10.1101/2023.08.01.23293515
Now published in npj Vaccines doi: 10.1038/s41541-023-00796-7
Francisco J. Martinez
1Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France
Michael White
2Infectious Disease Epidemiology and Analytics G5 Unit, Institut Pasteur, Université Paris Cité, Paris, France
Micheline Guillotte-Blisnick
1Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France
Christèle Huon
1Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France
Alix Boucharlat
3Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France
Fabrice Agou
3Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France
Patrick England
4Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France
Jean Popovici
5Malaria Reasearch Unit, Institut Pasteur du Cambodge, Pnom Penh, Cambodia
Mimi M. Hou
6Department of Biochemistry, University of Oxford; Oxford, OX1 3QU, UK
7The Jenner Institute, University of Oxford; Oxford, OX3 7DQ, UK
8Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK
Sarah E. Silk
6Department of Biochemistry, University of Oxford; Oxford, OX1 3QU, UK
7The Jenner Institute, University of Oxford; Oxford, OX3 7DQ, UK
8Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK
Jordan R. Barrett
6Department of Biochemistry, University of Oxford; Oxford, OX1 3QU, UK
7The Jenner Institute, University of Oxford; Oxford, OX3 7DQ, UK
8Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK
Carolyn M. Nielsen
6Department of Biochemistry, University of Oxford; Oxford, OX1 3QU, UK
7The Jenner Institute, University of Oxford; Oxford, OX3 7DQ, UK
8Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK
Jenny M. Reimer
9Novavax AB; Kungsgatan 109, SE-753 18, Uppsala, Sweden
Paushali Mukherjee
10Multi-Vaccines Development Program, ICGEB Campus, New Delhi, India
Virander S. Chauhan
11International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India
Angela M. Minassian
6Department of Biochemistry, University of Oxford; Oxford, OX1 3QU, UK
7The Jenner Institute, University of Oxford; Oxford, OX3 7DQ, UK
8Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK
12NIHR Oxford Biomedical Research Centre, Oxford, UK
Simon J. Draper
6Department of Biochemistry, University of Oxford; Oxford, OX1 3QU, UK
7The Jenner Institute, University of Oxford; Oxford, OX3 7DQ, UK
8Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK
12NIHR Oxford Biomedical Research Centre, Oxford, UK
Chetan E. Chitnis
1Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France

Data Availability
All data that support the findings of this study will be made available online with the manuscript.
Posted August 02, 2023.
PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial
Francisco J. Martinez, Michael White, Micheline Guillotte-Blisnick, Christèle Huon, Alix Boucharlat, Fabrice Agou, Patrick England, Jean Popovici, Mimi M. Hou, Sarah E. Silk, Jordan R. Barrett, Carolyn M. Nielsen, Jenny M. Reimer, Paushali Mukherjee, Virander S. Chauhan, Angela M. Minassian, Simon J. Draper, Chetan E. Chitnis
medRxiv 2023.08.01.23293515; doi: https://doi.org/10.1101/2023.08.01.23293515
Now published in npj Vaccines doi: 10.1038/s41541-023-00796-7
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3232)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13243)
- Forensic Medicine (19)
- Gastroenterology (890)
- Genetic and Genomic Medicine (5064)
- Geriatric Medicine (470)
- Health Economics (773)
- Health Informatics (3185)
- Health Policy (1129)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4807)
- Nursing (254)
- Nutrition (716)
- Oncology (2479)
- Ophthalmology (702)
- Orthopedics (279)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (529)
- Pediatrics (1279)
- Primary Care Research (550)
- Public and Global Health (7367)
- Radiology and Imaging (1668)
- Respiratory Medicine (969)
- Rheumatology (473)
- Sports Medicine (415)
- Surgery (534)
- Toxicology (69)
- Transplantation (232)
- Urology (199)